NasdaqGS - Nasdaq Real Time Price USD

Apyx Medical Corporation (APYX)

Compare
1.1800 +0.0050 (+0.43%)
As of 9:45 AM EDT. Market Open.
Loading Chart for APYX
DELL
  • Previous Close 1.1750
  • Open 1.1800
  • Bid 0.8496 x 200
  • Ask 1.5100 x 200
  • Day's Range 1.1800 - 1.1800
  • 52 Week Range 0.9670 - 3.4900
  • Volume 17,049
  • Avg. Volume 35,946
  • Market Cap (intraday) 40.88M
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) --
  • EPS (TTM) -0.8200
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.50

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

apyxmedical.com

252

Full Time Employees

December 31

Fiscal Year Ends

Recent News: APYX

View More

Research Reports: APYX

View More

Performance Overview: APYX

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APYX
54.96%
S&P 500
20.70%

1-Year Return

APYX
61.56%
S&P 500
34.72%

3-Year Return

APYX
90.55%
S&P 500
29.21%

5-Year Return

APYX
83.21%
S&P 500
93.35%

Compare To: APYX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: APYX

View More

Valuation Measures

Annual
As of 9/26/2024
  • Market Cap

    40.71M

  • Enterprise Value

    46.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    2.76

  • Enterprise Value/Revenue

    0.95

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -57.86%

  • Return on Assets (ttm)

    -21.83%

  • Return on Equity (ttm)

    -110.25%

  • Revenue (ttm)

    49.03M

  • Net Income Avi to Common (ttm)

    -28.37M

  • Diluted EPS (ttm)

    -0.8200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.68M

  • Total Debt/Equity (mrq)

    259.32%

  • Levered Free Cash Flow (ttm)

    3.78M

Research Analysis: APYX

View More

Company Insights: APYX

People Also Watch